The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 10, 2012
Filed:
Dec. 07, 2007
Robert K. Baker, Cranford, NJ (US);
Linda L. Chang, Wayne, NJ (US);
Marc Chioda, Metuchen, NJ (US);
Harry R. Chobanian, Aberdeen, NJ (US);
Ying-duo Gao, Edison, NJ (US);
Yan Guo, Westfield, NJ (US);
Linus S. Lin, Westfield, NJ (US);
Ping Liu, Westfield, NJ (US);
Ravi P. Nargund, East Brunswick, NJ (US);
Kathleen M. Rupprecht, Cranford, NJ (US);
Shouwu Miao, Edison, NJ (US);
Robert K. Baker, Cranford, NJ (US);
Linda L. Chang, Wayne, NJ (US);
Marc Chioda, Metuchen, NJ (US);
Harry R. Chobanian, Aberdeen, NJ (US);
Ying-Duo Gao, Edison, NJ (US);
Yan Guo, Westfield, NJ (US);
Linus S. Lin, Westfield, NJ (US);
Ping Liu, Westfield, NJ (US);
Ravi P. Nargund, East Brunswick, NJ (US);
Kathleen M. Rupprecht, Cranford, NJ (US);
Shouwu Miao, Edison, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
Certain novel substituted diazepine sulfonamides are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.